Skip to main content

McKesson

McKesson Corporation is an American healthcare infrastructure enterprise that engages in pharmaceutical wholesale distribution, medical supply chain management, and health technology services. The company organizes its business operations across four primary reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. Its product and service portfolio encompasses wholesale distribution of branded, generic, and specialty pharmaceuticals, medical-surgical supplies, plasma products, oncology logistics, and pharmacy software. Principal revenue drivers consist of high-volume wholesale drug distribution contracts with major retail pharmacy networks, independent pharmacies, and institutional healthcare facilities. McKesson serves diverse global end markets comprising retail pharmacy chains, hospital systems, physician clinics, ambulatory surgery centers, and pharmaceutical manufacturing partners. The enterprise maintains a market-leading global position as one of the top wholesale pharmaceutical distributors in North America, processing a substantial share of all prescription medicines sold in the United States. Headquartered in Irving, Texas, the company's common stock is publicly traded on the New York Stock Exchange under the ticker symbol MCK and is included in the Fortune 500 and S&P 500 indices.

124 of the funds FundTelligence covers report a position in McKesson.

Legal name
McKesson Corp.
Sector
Health Care
Country
United States
Funds holding it
124

Funds holding McKesson

Showing the 8 largest of 124 funds holding it.

Loading...